Dr. Mark Scholz on Advances in Prostate Cancer Imaging

Mark C. Scholz, MD
Published: Friday, May 10, 2013

Mark C. Scholz, MD, medical director, Prostate Oncology Specialists Inc. in Marina del Rey, CA, describes his excitement over advances in prostate cancer imaging techniques.

Detecting and screening for prostate cancer using multiparametric MRI has the potential to impact two areas, Scholz explains. First, studies have shown that in some cases imaging can be effectively substituted for a routine biopsy. Secondly, Scholz notes, this approach could be used to monitor patients on active surveillance.

The potential to utilize imaging to reduce the number of biopsies is exciting, Scholz believes, particularly since biopsies may lead to serious infections and overdiagnosis in early stage prostate cancer.

Mark C. Scholz, MD, medical director, Prostate Oncology Specialists Inc. in Marina del Rey, CA, describes his excitement over advances in prostate cancer imaging techniques.

Detecting and screening for prostate cancer using multiparametric MRI has the potential to impact two areas, Scholz explains. First, studies have shown that in some cases imaging can be effectively substituted for a routine biopsy. Secondly, Scholz notes, this approach could be used to monitor patients on active surveillance.

The potential to utilize imaging to reduce the number of biopsies is exciting, Scholz believes, particularly since biopsies may lead to serious infections and overdiagnosis in early stage prostate cancer.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x